RxDoctor Payments DataLook up a doctor →

Kathleen Kearney, MD

Interventional Cardiology · Seattle, WANPI 1144459462

Payments from drug & device makers

$802,006in general payments, 2019–2025

Across 708 payments — averaging $1132.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arrow International, Inc.$209K
  • Boston Scientific$177K
  • Abbott$112K
  • Medtronic$96K
  • Shockwave Medical, Inc$55K
  • Abiomed$52K
  • plus $100K from 16 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$802,006 in reported general payments places this provider in the 95th percentile of 125 interventional cardiology providers in Washington.

See all interventional cardiology providers in Washington

Medicare billing

Part B allowed, 2024
$113,800
Medicare patients
169
Services billed
618

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →